Co-Diagnostics - 8 Year Stock Price History | CODX
- The all-time high Co-Diagnostics stock closing price was 30.80 on August 03, 2020.
- The Co-Diagnostics 52-week high stock price is 2.23, which is 214.1% above the current share price.
- The Co-Diagnostics 52-week low stock price is 0.65, which is 8.5% below the current share price.
- The average Co-Diagnostics stock price for the last 52 weeks is 1.12.
Co-Diagnostics Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2025 | 0.7604 | 0.7226 | 1.0000 | 0.6740 | 0.7080 | -5.60% |
2024 | 1.1876 | 1.4200 | 1.7500 | 0.6999 | 0.7500 | -43.61% |
2023 | 1.5923 | 2.5300 | 3.2400 | 1.0000 | 1.3300 | -47.22% |
2022 | 4.9293 | 9.3100 | 9.6100 | 2.3200 | 2.5200 | -71.78% |
2021 | 10.0542 | 9.9700 | 19.2100 | 7.1600 | 8.9300 | -3.98% |
2020 | 12.6610 | 0.9103 | 30.8000 | 0.9103 | 9.3000 | 938.87% |
2019 | 1.0546 | 1.5500 | 2.2400 | 0.7120 | 0.8952 | -39.92% |
2018 | 2.6845 | 2.7600 | 5.2800 | 1.1500 | 1.4900 | -43.56% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.022B | $0.007B |
Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $148.052B | 27.37 |
Elevance Health (ELV) | United States | $90.846B | 11.88 |
CVS Health (CVS) | United States | $83.717B | 12.25 |
Cencora (COR) | United States | $47.591B | 17.27 |
DiDi Global (DIDIY) | China | $23.087B | 0.00 |
Natera (NTRA) | United States | $22.788B | 0.00 |
ICON (ICLR) | Ireland | $15.783B | 14.04 |
Doximity (DOCS) | United States | $14.316B | 74.45 |
BioMerieux (BMXMF) | France | $14.074B | 0.00 |
Revvity (RVTY) | United States | $13.997B | 23.47 |
Viatris (VTRS) | United States | $13.046B | 4.02 |
Solventum (SOLV) | United States | $12.780B | 0.00 |
Avantor (AVTR) | United States | $12.038B | 17.68 |
CochLear (CHEOY) | Australia | $11.471B | 0.00 |
Medpace Holdings (MEDP) | United States | $10.479B | 27.23 |
HealthEquity (HQY) | United States | $9.860B | 49.47 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $9.450B | 0.00 |
Sonic Healthcare (SKHHY) | Australia | $8.815B | 0.00 |
Charles River Laboratories (CRL) | United States | $8.437B | 15.99 |
Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
Bausch + Lomb (BLCO) | Canada | $5.745B | 26.29 |
Organon (OGN) | United States | $3.938B | 4.01 |
Sotera Health (SHC) | United States | $3.861B | 20.65 |
BrightSpring Health Services (BTSG) | United States | $3.639B | 77.41 |
Surgery Partners (SGRY) | United States | $3.282B | 37.42 |
GeneDx Holdings (WGS) | United States | $3.058B | 371.03 |
Concentras Parent (CON) | United States | $2.973B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.699B | 0.00 |
Teladoc Health (TDOC) | United States | $2.371B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.078B | 0.00 |
Progyny (PGNY) | United States | $2.017B | 40.85 |
PACS (PACS) | United States | $2.006B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.955B | 51.30 |
Premier (PINC) | United States | $1.711B | 10.96 |
Agilon Health (AGL) | United States | $1.471B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
CareDx (CDNA) | United States | $1.325B | 0.00 |
Pediatrix Medical (MD) | United States | $1.212B | 11.86 |
Establishment Labs Holdings (ESTA) | $1.010B | 0.00 | |
AMN Healthcare Services Inc (AMN) | United States | $0.908B | 6.14 |
Embecta (EMBC) | United States | $0.899B | 6.16 |
Auna S.A (AUNA) | Luxembourg | $0.633B | 0.00 |
DocGo (DCGO) | United States | $0.562B | 21.19 |
Sonida Senior Living (SNDA) | United States | $0.499B | 0.00 |
SBC Medicals (SBC) | United States | $0.483B | 0.00 |
MultiPlan (MPLN) | United States | $0.476B | 0.00 |
InnovAge Holding (INNV) | United States | $0.453B | 0.00 |
Enhabit (EHAB) | United States | $0.440B | 38.09 |
Nutex Health (NUTX) | United States | $0.352B | 0.00 |
LifeMD (LFMD) | United States | $0.345B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.308B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.294B | 7.71 |
Beauty Health (SKIN) | United States | $0.210B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.183B | 0.00 |
Sera Prognostics (SERA) | United States | $0.144B | 0.00 |
Biodesix (BDSX) | United States | $0.138B | 0.00 |
So-Young (SY) | China | $0.118B | 19.98 |
IceCure Medical (ICCM) | Israel | $0.086B | 0.00 |
ModivCare (MODV) | United States | $0.082B | 4.46 |
Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
Oncology Institute (TOI) | United States | $0.073B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 1.60 |
Singular Genomics Systems (OMIC) | United States | $0.051B | 0.00 |
OncoCyte (OCX) | United States | $0.048B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
Pheton Holdings (PTHL) | China | $0.020B | 0.00 |
KindlyMD (KDLY) | United States | $0.016B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
XWELL (XWEL) | United States | $0.006B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |